SESSION I: FIXED VS CONTINUOUS TREATMENTS IN HIGH-RISK PATIENTS
SESSION II: NEW SCENARIOS IN CLL
M. Coscia (Varese) - NON AUTORIZZATA
A. Pinto (Napoli) - NON AUTORIZZATA
SESSION IV: NEW PERSPECTIVES IN R/R DLBCL
M. Martino (Reggio Calabria)
SESSION V: CONTROVERSIES IN R/R FL
SESSION VI: LYMPHOMAS QUESTIONS and ANSWERS